| Followers | 74 |
| Posts | 1809 |
| Boards Moderated | 0 |
| Alias Born | 04/02/2010 |
Saturday, June 30, 2012 11:38:07 AM
12
http://www.scribd.com/doc/98737491
Filed & Entered: 06/29/2012
Order Re: Motion to Authorize
Docket Text: Interim Order Signed on 6/29/2012 (A) Authorizing the Debtor to (1) Pay and Honor Certain Prepetition Claims for (I) Wages, Salaries, Employee Benefits and Other Compensation and (II) Withholdings and Deductions; (2) Continue to Provide Employee Benefits in the Ordinary Course of Business; (3) Pay All Related Costs and Expenses; and (B) Directing Banks to Receive, Process, Honor and Pay All Checks Presented for Payment and Electronic Payment Requests Relating to the Foregoing. (Related Doc # 5) (Nulty, Lynda)
13
http://www.scribd.com/doc/98737497
Filed & Entered: 06/29/2012
Order Re: Motion to Approve Use of Cash Collateral
Docket Text: Interim Order Signed on 6/29/2012 (I) Authorizing the Debtor to Utilize Cash Collateral of Prepetition Secured Lenders, (II) Granting Adequate Protection to the Prepetition Secured Lenders, (III) Granting Related Relief and (IV) Scheduling a Final Hearing for 7/24/12 at 10:00 a.m. in Courtroom 601. (Related Doc # 4) (Nulty, Lynda)
14
http://www.scribd.com/doc/98737484
Filed & Entered: 06/29/2012
Notice of Appearance
Docket Text: Notice of Appearance and Request for All Notices filed by David S Caplan on behalf of The Billing Resource, LLC. (Caplan, David)
"All Truth, In The Long Run, Is Only Common Sense Clarified. ~ Thomas H. Huxley
"Facts Do Not Cease To Exist Because They Are Ignored." ~ Aldous Huxley
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
